Sacral neuromodulation, also known as sacral nerve stimulation, is a
type of electrical stimulation. Sacral neuromodulation system is an
implanted system that can help improve the functioning of the bladder
by sending electrical signals to the nerves, which control bladder
activities. According to a study on neuromodulation devices and
therapies, neuromodulation is a safe, effective, and long term
treatment for chronic pain and movement disorders.
Report Overview @
https://www.transparencymarketresearch.com/sacral-neuromodulation-systems-market.html
Neuromodulation technology is gaining momentum in biotechnology, led
by its extensive therapeutic scope. It is primarily used as a
treatment for unmanageable chronic pain or movement conditions.
Sacral nerve stimulation is a treatment used for the overactive
bladder. It is vital when a person is unable to voluntary control
bodily functions of urination. It is a condition wherein there is
unintentional loss of urine from body. In some cases, sacral
neuromodulation effectively treats fecal incontinence. Sacral
neuromodulation is a process, wherein small electrodes are placed
under the skin where the bladder nerves are present. These electrodes
are attached to a small device, which can help restore the normal
function of the bladder. This device can be easily removed by the
concerned individual or a physician; it can also be placed
permanently if necessary.
Sacral neuromodulation is a minimally invasive and reversible
process. The procedure is anticipated to be a treatment for
overreacting bladder symptoms including urgency frequency syndrome
(it is a form of voiding dysfunction characterized by an uncontrolled
urge to void, resulting in frequent urine voided than is normally
expected) and urge urinary incontinence (involuntary leakage of
urine) for patients who cannot tolerate conservative treatments.
Sacral neuromodulation provides sustainable symptom relief in
carefully-selected patients, thereby avoiding repeated treatment with
botulinum toxin A or irreversible surgery.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28247
Chronic pain or movement dysfunction are not life threatening
disorder; however, it may negative affect the patient’s quality of
life by hampering the ability to work and function socially. Many
patients with incontinence feel uncomfortable sharing their problem
with physicians, thus posing a major challenge to identify the rate
of incidence. However, increase in medical campaigns about these
conditions and changing demographics are expected to fuel the demand
for incontinence products. Other options such as physiotherapy and
pelvic floor exercises, drug treatment (tablets), and bladder
re-training can be uses as alternative treatments. Permanent
treatment options such as bladder enlargement or replacement using
bowel, and urinary diversion into the stoma are also available.
However, the sacral neuromodulation method is gaining popularity
among patients with lower urinary tract symptoms and pelvic organ
prolapse, as it is safer than other surgical methods such as
augmentation cystoplasty. The high cost of implant is anticipated to
hamper the sacral neuromodulation systems market. However, proven
efficacy and lack of other acceptable treatment methods are estimated
to boost the sacral neuromodulation systems market, particularly in
developing regions across the world.
Based on geography, the global sacral neuromodulation systems market
can be segmented into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America is expected to
be a key region of the market, due to the high obesity rate and
increase in stress incontinence. Europe is projected to follow North
America owing to the presence of large number of aging population in
the region. The prevalence of urinary incontinence and overactive
bladder increases with age. However, the market in Asia is likely to
expand at a rapid pace due to the rise in awareness about newly
advanced healthcare treatments, gradual rise in adoption of improved
technologies, growth in health care infrastructure, increase in
purchasing power of end user’s and rising population.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=28247<ype=S
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment